How Often Should I Get a CBC for Polycythemia Vera?
At a Glance
For polycythemia vera, CBC and hematocrit checks are often done every 1 to 2 weeks or monthly when treatment starts or changes, then every 3 to 4 months once counts are stable, while keeping hematocrit below 45%. Your hematology team sets the schedule.
In this answer
3 sections
Living with polycythemia vera (PV) requires an ongoing commitment to monitoring your blood. The frequency of checking your Complete Blood Count (CBC) and hematocrit depends heavily on your specific treatment plan, current medications, and how your body responds.
As a general rule, during the initial treatment and dose-adjustment period, you may need your blood drawn every 1 to 2 weeks, or at least monthly. During long-term, ongoing follow-up when your blood counts become consistently stable, these checks often decrease to every 3 to 4 months. These intervals are typical examples; your hematology team will set a personalized schedule based on your specific needs.
The Goal of Monitoring: Staying Under 45%
A primary goal of treating polycythemia vera is to keep your hematocrit (the percentage of your blood volume made up of red blood cells) below 45% [1]. Uncontrolled red blood cell levels thicken the blood, and keeping your hematocrit below this 45% threshold is critical for reducing the risk of cardiovascular events and dangerous blood clots (thrombosis) [1][2]. Try not to panic if a single lab result comes back slightly above 45%; your doctor will look at your overall trends alongside your symptoms to decide if a treatment change is needed.
While hematocrit is the main focus, your doctor will order a full CBC rather than just a hematocrit test. A CBC also measures your white blood cells and platelets (cell fragments that help your blood clot), which can also be elevated in PV [3]. Monitoring the complete picture is important because high blood counts increase the risk of thrombosis and microvascular symptoms, such as headache, visual disturbances, or erythromelalgia (severe burning pain and redness in the hands and feet) [3].
🚨 When to Seek Emergency Care
Do not wait for a scheduled blood test or call your doctor’s office for a routine CBC if you experience acute symptoms. Call 911 or go to the nearest emergency room immediately if you experience sudden severe headache, facial drooping, one-sided weakness or numbness, trouble speaking, sudden vision loss, chest pain, sudden shortness of breath, coughing up blood, or a painful swollen leg. These can be signs of a stroke, pulmonary embolism, or another serious blood clot [3].
Initial Treatment and Dose Adjustment
This phase occurs immediately after diagnosis, when starting a new treatment, or when adjusting the dose of a medication like hydroxyurea, interferon, or ruxolitinib. Because every patient’s body responds differently to cytoreductive medications (drugs that lower blood counts), your care team needs to monitor you closely [4].
During this time, you may need frequent phlebotomies—a procedure similar to a blood donation where blood is physically removed—until your hematocrit safely reaches your target [5]. Getting a CBC every 1 to 2 weeks or monthly ensures that your hematocrit is dropping safely, your other cell counts aren’t dropping too low from medication, and your treatment doses are being adjusted correctly.
Long-Term Ongoing Follow-Up
Once your hematocrit stays consistently below 45% and your other blood counts are stable, your logistical burden will likely ease, with blood checks spaced out to every 3 to 4 months.
However, stable intervals do not mean the condition is no longer active. PV is a chronic condition that can progress over time [6]. For instance, if you are taking a medication like hydroxyurea but persistently need phlebotomies to keep your hematocrit down, research shows this may indicate a suboptimal treatment response and a higher risk for blood clots [7]. Routine blood work every few months allows your care team to catch these subtle trends.
Finally, while the CBC is central to PV care, it is not the only test you need. Depending on your treatment, your doctor may also periodically check your kidney function, liver function, and iron levels (as frequent phlebotomies can cause iron deficiency). You generally do not need to fast for a standard CBC, but you should arrive well-hydrated unless your doctor tells you otherwise. Always ask your clinician before starting any iron supplements, even if you feel excessively fatigued.
Common questions in this guide
How often is a CBC checked when polycythemia vera treatment starts?
How often is blood work needed once polycythemia vera is stable?
Why does polycythemia vera monitoring focus on a hematocrit below 45%?
What does a CBC show in polycythemia vera?
When should I go to the emergency room instead of waiting for a CBC?
What other tests might I need besides a CBC for polycythemia vera?
Do I need to fast before a polycythemia vera CBC?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my specific target for hematocrit, and how close am I to reaching it?
- 2.How many consecutive stable blood tests do you usually want to see before spacing my appointments out to every 3 to 4 months?
- 3.What specific symptoms should prompt me to call your office for a same-day review versus going straight to the emergency room?
- 4.Besides a CBC, what other lab tests (like iron, kidney, or liver panels) do I need based on my current medications?
- 5.If my hematocrit creeps above 45% on a single test, how do we decide whether to adjust my medication or wait for the next draw?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (7)
- 1
Contemporary approach to essential thrombocythemia and polycythemia vera.
Aruch D, Mascarenhas J
Current opinion in hematology 2016; (23(2)):150-60 doi:10.1097/MOH.0000000000000216.
PMID: 26717193 - 2
Polycythemia vera: diagnosis, clinical course, and current management
Büyükaşik Y, Alİ R, Ar C, et al.
Turkish journal of medical sciences 2018; (48(4)):698-710 doi:10.3906/sag-1806-43.
PMID: 30114348 - 3
Refining the management of polycythemia vera.
Mesa RA
Clinical advances in hematology & oncology : H&O 2018; (16(9)):587-589.
PMID: 30256773 - 4
Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Dam MJB, Pedersen RK, Knudsen TA, et al.
European journal of haematology 2021; (107(6)):624-633 doi:10.1111/ejh.13700.
PMID: 34411333 - 5
Central retinal artery occlusion as a presenting manifestation of polycythaemia vera.
Rao K, Shenoy SB, Kamath Y, Kapoor S
BMJ case reports 2016; (2016()) doi:10.1136/bcr-2016-216417.
PMID: 27797860 - 6
No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials.
Barbui T, Carobbio A, Ghirardi A, et al.
Haematologica 2017; (102(6)):e219-e221 doi:10.3324/haematol.2017.165126.
PMID: 28255021 - 7
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
Alvarez-Larrán A, Pérez-Encinas M, Ferrer-Marín F, et al.
Haematologica 2017; (102(1)):103-109 doi:10.3324/haematol.2016.152769.
PMID: 27686377
This page is for informational purposes only and does not constitute medical advice about your polycythemia vera. Your hematology team should set your testing schedule and assess any urgent symptoms.
Get notified when new evidence is published on Polycythemia vera.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.